NORD

Nordicus Partners Corporation

$2.95

-16.22%

SectorHealthcareIndustryBiotechnologyCountryUnited States

Overview AI Brief ChartChart & Performance Financials ExposureRevenue Exposure FilingsFilings & Red Flags ScoresScores & Valuation News Analysts InsidersInsiders & Short Interest Ownership

Nordicus Partners Corporation, a biotech company specializing in developing breakthrough therapeutics for diseases with unmet medical needs in the United States. It develops medicines supporting oral health. The company was formerly known as EKIMAS Corporation and changed its name to Nordicus Partners Corporation in May 2023. Nordicus Partners Corporation was founded in 1993 and is based in Beverly Hills, California.

Source: Yahoo Finance

Market Cap$57.3M

Dividend Yield0.00%

Beta0.13

AI summary

Price & performance

1M+39.9%

3M+118.3%

YTD-1.8%

1Y-1.8%

52-week range—

Beta0.13

Full chart and returns against a benchmark

Q-Score

53/ 100

Quality against peers; 50 is the peer median.

Growth47

Risk35

Performance68

Valuation67

Profitability56

Leverage13

Sentiment—

Every score and metric

News sentiment

Open News

Latest results · FY 2026

Revenue—

Net income-$4M

Net margin—

Historical fundamentals

Red flags in filings

3active red flags

Going-concern doubtJul 14, 2026

Material weakness in controlsJul 14, 2026

Late filing noticeAug 13, 2026

Filings, findings and the timeline

Revenue exposure

Regions, segments, customers and suppliers

Valuation

NORDIndustryP/E—89.69P/S—11.88EV/EBITDA—67.10P/B0.936.22PEG—4.02

Dividend yield0.00%

Every valuation metric

Historical Fundamentals

Revenue

Net Income

Showing the last 4 periods. Pro adds the full annual and quarterly history and 20+ more metrics to chart.

Latest Results

The latest fiscal year and quarter, each against the same period a year earlier, from SEC filings.

Metric	FY 2026	vs a year before	Q2 2026	vs a year before
Net Income	-$4M	—	-$2.3M	—

Q-Scores

OverallCombines the categories below, except Sentiment

Industry 5753

Growth

Industry 7947

Risk

Industry 5535

Performance

Industry 6668

Valuation

Industry 2567

Profitability

Industry 4756

Leverage

Industry 6813

Key Metrics

Fundamentals: trailing twelve months to Jun 2026, from the latest 10-K and 10-Qs.

Market Beta (5-factor)

IM 0.72SM 0.786.96

Market Cap

57.3M

Dividend Yield

IM 0.00%SM 0.00%0.00%

Volume

IM 693.1KSM 741.7K7K

Industry Market Share

0.00%

Sector Market Share

0.00%

IM industry median · SM sector median: the typical company the value is compared with. The /100 is its score against those peers.

Comparable Companies

The companies closest in size in Biotechnology (filled from its sector when there are few), with the median and rank across all 571 in the industry.

Company	Market cap	P/E	EV/EBITDA	P/S	P/B	FCF yield	Revenue growth	Op. margin	ROE	Debt/equity
NORDNordicus Partners Corporation	$57.3M	—	—	—	0.9	-7.1%	—	—	-8.2%	0.0
RNXTRenovoRx, Inc.	$56.9M	—	—	20.5	6.1	-21.5%	—	-489.0%	-140.2%	0.0
BOLDBoundless Bio, Inc.	$56.8M	—	—	—	0.9	-99.9%	—	—	-97.0%	0.0
XLOXilio Therapeutics, Inc.	$56.1M	—	—	0.9	0.8	-109.2%	327.3%	-48.9%	-30.2%	0.0
SPROSpero Therapeutics, Inc.	$58.8M	8.0	1.3	4.7	1.3	33.3%	—	47.9%	16.7%	0.0
XBITXBiotech Inc.	$60.1M	—	—	—	0.5	-68.0%	—	—	-35.1%	0.0
VRCAVerrica Pharmaceuticals Inc.	$60.5M	—	—	2.0	14.0	-22.1%	106.2%	-93.6%	-724.0%	0.0
APLMApollomics, Inc.	$54.2M	—	—	—	11.1	-53.1%	—	—	—	0.0
CRDFCardiff Oncology, Inc.	$61.8M	—	—	121.7	2.3	-66.2%	-6.8%	—	-151.0%	0.0
Industry median		11.7	20.2	7.7	2.2	-22.3%	12.8%	-76.9%	-60.8%	0.0
NORD percentile		—	—	—	26th	73rd	—	—	87th	39th